Please enable JavaScript to continue using this application.

Compare $RNAC vs $SION | Chartloom

Compare

$RNAC vs $SION

Cartesian Therapeutics Inc · Sionna Therapeutics Inc

RNAC

Cartesian Therapeutics Inc

SION

Sionna Therapeutics Inc

Compare $RNAC vs $SION

Comparing Cartesian Therapeutics Inc and Sionna Therapeutics Inc

RNACCartesian Therapeutics Inc

SIONSionna Therapeutics Inc

RNACCartesian Therapeutics Inc

Market cap

$207M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

473.62x

Rev growth (TTM)

-20.7%

YTD performance

4.4%

52W performance

-31.0%

FCF yield

-37.9%

SIONSionna Therapeutics Inc

Market cap

$221M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-87.5%

52W performance

-82.8%

FCF yield

-34.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RNAC

SION

Detailed metrics comparison

RNAC

Cartesian Therapeutics Inc

SION

Sionna Therapeutics Inc

Market Cap

RNAC$207M

SION$221M

Enterprise Value

RNAC$113M

SION$158M

Price

RNAC$7.06

SION$4.90

P/E Ratio

RNACN/A

SIONN/A

P/S Ratio

RNAC140.34x

SION0.00x

EV/Sales

RNAC76.18x

SION0.00x

EV/EBITDA

RNAC0.00x

SION0.00x

P/B Ratio

RNAC296.12x

SION0.84x

P/FCF Ratio

RNACN/A

SIONN/A

EV/FCF

RNAC-1.43x

SION-2.07x

PEG Ratio

RNACN/A

SIONN/A

Forward P/E (NTM)

RNACN/A

SIONN/A

Forward P/S (NTM)

RNAC473.62x

SIONN/A

Revenue (TTM)

RNAC$1M

SION$0

Revenue Growth (YoY)

RNAC-20.7%

SIONN/A

Forward Rev Growth

RNAC-14.0%

SION1297.1%

Gross Margin (TTM)

RNAC0.0%

SION0.0%

Operating Margin (TTM)

RNAC0.0%

SION0.0%

EBITDA Margin (TTM)

RNAC-6503.1%

SION0.0%

Net Margin (TTM)

RNAC-10422.5%

SION0.0%

FCF Margin (TTM)

RNAC-5322.4%

SIONN/A

Net Income (TTM)

RNAC$-154M

SION$-97M

FCF (TTM)

RNAC$-79M

SION$-76M

EPS (TTM)

RNAC-$5.16

SION-$2.16

ROE (TTM)

RNAC-321582.0%

SION-3294.0%

ROA (TTM)

RNAC-4761.0%

SION-3108.0%

ROIC (TTM)

RNAC-321582.0%

SION-3294.0%

Cash

RNAC$148M

SION$63M

Debt

RNAC$53M

SION$0

Net Cash/Debt

RNAC$95M

SION$63M

Current Ratio (TTM)

RNAC7.48x

SION20.05x

Quick Ratio (TTM)

RNAC7.19x

SION19.57x

Debt/Equity (TTM)

RNAC0.28x

SION0.00x

Debt/Assets (TTM)

RNAC0.0%

SION0.0%

Interest Coverage (TTM)

RNACN/A

SIONN/A

Net Debt/EBITDA (TTM)

RNAC0.00x

SION0.00x

Beta

RNAC0.74

SION1.44

52W Performance

RNAC-31.0%

SION-82.8%

YTD Performance

RNAC4.4%

SION-87.5%

% from 52W High

RNAC-35.9%

SION-91.1%

% from 52W Low

RNAC26.0%

SION22.2%

Asset Turnover (TTM)

RNAC0.01x

SION0.00x

FCF Yield (TTM)

RNAC-37.9%

SION-34.4%

Earnings Yield (TTM)

RNAC-74.3%

SION-44.0%

Dividend Yield (TTM)

RNACN/A

SIONN/A

Rule of 40

RNAC-5,343.1

SION0.0

EV/GP/RG

RNACN/A

SIONN/A

Ticker research

View RNAC research View SION research

Metric	RNAC Cartesian Therapeutics Inc	SION Sionna Therapeutics Inc
Market & Valuation
Market Cap	$207M	$221M
Enterprise Value	$113M	$158M
Price	$7.06	$4.90
P/E Ratio	N/A	N/A
P/S Ratio	140.34x	0.00x
EV/Sales	76.18x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	296.12x	0.84x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.43x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	473.62x	N/A
Revenue & Growth
Revenue (TTM)	$1M	$0
Revenue Growth (YoY)	-20.7%	N/A
Forward Rev Growth	-14.0%	1297.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-6503.1%	0.0%
Net Margin (TTM)	-10422.5%	0.0%
FCF Margin (TTM)	-5322.4%	N/A
Net Income (TTM)	$-154M	$-97M
FCF (TTM)	$-79M	$-76M
EPS (TTM)	-$5.16	-$2.16
ROE (TTM)	-321582.0%	-3294.0%
ROA (TTM)	-4761.0%	-3108.0%
ROIC (TTM)	-321582.0%	-3294.0%
Financial Health
Cash	$148M	$63M
Debt	$53M	$0
Net Cash/Debt	$95M	$63M
Current Ratio (TTM)	7.48x	20.05x
Quick Ratio (TTM)	7.19x	19.57x
Debt/Equity (TTM)	0.28x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.74	1.44
52W Performance	-31.0%	-82.8%
YTD Performance	4.4%	-87.5%
% from 52W High	-35.9%	-91.1%
% from 52W Low	26.0%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-37.9%	-34.4%
Earnings Yield (TTM)	-74.3%	-44.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-5,343.1	0.0
EV/GP/RG	N/A	N/A
Ticker research	View RNAC research	View SION research

Valuation

P/S Ratio

SION

0.00x

RNAC

140.34x

EV/FCF

SION

-2.07x

RNAC

-1.43x

Growth & revenue

Revenue Growth TTM

RNAC

-20.7%

Forward Revenue Growth

SION

1297.1%

RNAC

-14.0%

Profitability & performance

Gross Margin

RNAC

0.0%

SION

0.0%

ROE

SION

-3294.0%

RNAC

-321582.0%

FCF Yield %

SION

-34.4%

RNAC

-37.9%

52-Week Performance

RNAC

-31.0%

SION

-82.8%

Detailed metrics comparison

RNAC

Cartesian Therapeutics Inc

SION

Sionna Therapeutics Inc

Market Cap

RNAC$207M

SION$221M

Enterprise Value

RNAC$113M

SION$158M

Price

RNAC$7.06

SION$4.90

P/E Ratio

RNACN/A

SIONN/A

P/S Ratio

RNAC140.34x

SION0.00x

EV/Sales

RNAC76.18x

SION0.00x

EV/EBITDA

RNAC0.00x

SION0.00x

P/B Ratio

RNAC296.12x

SION0.84x

P/FCF Ratio

RNACN/A

SIONN/A

EV/FCF

RNAC-1.43x

SION-2.07x

PEG Ratio

RNACN/A

SIONN/A

Forward P/E (NTM)

RNACN/A

SIONN/A

Forward P/S (NTM)

RNAC473.62x

SIONN/A

Revenue (TTM)

RNAC$1M

SION$0

Revenue Growth (YoY)

RNAC-20.7%

SIONN/A

Forward Rev Growth

RNAC-14.0%

SION1297.1%

Gross Margin (TTM)

RNAC0.0%

SION0.0%

Operating Margin (TTM)

RNAC0.0%

SION0.0%

EBITDA Margin (TTM)

RNAC-6503.1%

SION0.0%

Net Margin (TTM)

RNAC-10422.5%

SION0.0%

FCF Margin (TTM)

RNAC-5322.4%

SIONN/A

Net Income (TTM)

RNAC$-154M

SION$-97M

FCF (TTM)

RNAC$-79M

SION$-76M

EPS (TTM)

RNAC-$5.16

SION-$2.16

ROE (TTM)

RNAC-321582.0%

SION-3294.0%

ROA (TTM)

RNAC-4761.0%

SION-3108.0%

ROIC (TTM)

RNAC-321582.0%

SION-3294.0%

Cash

RNAC$148M

SION$63M

Debt

RNAC$53M

SION$0

Net Cash/Debt

RNAC$95M

SION$63M

Current Ratio (TTM)

RNAC7.48x

SION20.05x

Quick Ratio (TTM)

RNAC7.19x

SION19.57x

Debt/Equity (TTM)

RNAC0.28x

SION0.00x

Debt/Assets (TTM)

RNAC0.0%

SION0.0%

Interest Coverage (TTM)

RNACN/A

SIONN/A

Net Debt/EBITDA (TTM)

RNAC0.00x

SION0.00x

Beta

RNAC0.74

SION1.44

52W Performance

RNAC-31.0%

SION-82.8%

YTD Performance

RNAC4.4%

SION-87.5%

% from 52W High

RNAC-35.9%

SION-91.1%

% from 52W Low

RNAC26.0%

SION22.2%

Asset Turnover (TTM)

RNAC0.01x

SION0.00x

FCF Yield (TTM)

RNAC-37.9%

SION-34.4%

Earnings Yield (TTM)

RNAC-74.3%

SION-44.0%

Dividend Yield (TTM)

RNACN/A

SIONN/A

Rule of 40

RNAC-5,343.1

SION0.0

EV/GP/RG

RNACN/A

SIONN/A

Ticker research

View RNAC research View SION research

Metric	RNAC Cartesian Therapeutics Inc	SION Sionna Therapeutics Inc
Market & Valuation
Market Cap	$207M	$221M
Enterprise Value	$113M	$158M
Price	$7.06	$4.90
P/E Ratio	N/A	N/A
P/S Ratio	140.34x	0.00x
EV/Sales	76.18x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	296.12x	0.84x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.43x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	473.62x	N/A
Revenue & Growth
Revenue (TTM)	$1M	$0
Revenue Growth (YoY)	-20.7%	N/A
Forward Rev Growth	-14.0%	1297.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-6503.1%	0.0%
Net Margin (TTM)	-10422.5%	0.0%
FCF Margin (TTM)	-5322.4%	N/A
Net Income (TTM)	$-154M	$-97M
FCF (TTM)	$-79M	$-76M
EPS (TTM)	-$5.16	-$2.16
ROE (TTM)	-321582.0%	-3294.0%
ROA (TTM)	-4761.0%	-3108.0%
ROIC (TTM)	-321582.0%	-3294.0%
Financial Health
Cash	$148M	$63M
Debt	$53M	$0
Net Cash/Debt	$95M	$63M
Current Ratio (TTM)	7.48x	20.05x
Quick Ratio (TTM)	7.19x	19.57x
Debt/Equity (TTM)	0.28x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.74	1.44
52W Performance	-31.0%	-82.8%
YTD Performance	4.4%	-87.5%
% from 52W High	-35.9%	-91.1%
% from 52W Low	26.0%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-37.9%	-34.4%
Earnings Yield (TTM)	-74.3%	-44.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-5,343.1	0.0
EV/GP/RG	N/A	N/A
Ticker research	View RNAC research	View SION research